Over-expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis. - Wikidata - awgldk - TriplyDB

Over-expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis.

Over-expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis.

http://www.wikidata.org/entity/Q42447593

about

Molecular mechanism of interleukin-2-induced mucosal homeostasis A review on chemical-induced inflammatory bowel disease models in rodents Selective Th2 pattern of cytokine secretion in Mycobacterium avium subsp. paratuberculosis infected Crohn's disease Orally administered glucans from the edible mushroom Pleurotus pulmonarius reduce acute inflammation in dextran sulfate sodium-induced experimental colitis.Differential dose effects of recombinant IL-25 on the development of dextran sulfate sodium-induced colitis.Label-free electrochemical detection of human methyltransferase from tumors.Janus kinase 3 regulates interleukin 2-induced mucosal wound repair through tyrosine phosphorylation of villin.Preventive and therapeutic effects of NF-kappaB inhibitor curcumin in rats colitis induced by trinitrobenzene sulfonic acid Longitudinal analysis of inflammation and microbiota dynamics in a model of mild chronic dextran sulfate sodium-induced colitis in mice.Cyclosporine A regulates pro-inflammatory cytokine production in ulcerative colitis.STAT3-Activating Cytokines: A Therapeutic Opportunity for Inflammatory Bowel Disease?Combination of Azathioprine and Aminosalicylate Treatment Prevent Risk of Cardiovascular Disease in Women with Ulcerative Colitis by Reducing Inflammation.Deubiquitinating enzyme CYLD negatively regulates the ubiquitin-dependent kinase Tak1 and prevents abnormal T cell responses.Hypothesis about mechanisms through which nicotine might exert its effect on the interdependence of inflammation and gut barrier function in ulcerative colitis.Pathogenic angiogenesis in IBD and experimental colitis: new ideas and therapeutic avenues.Activation of an IL-6:STAT3-dependent transcriptome in pediatric-onset inflammatory bowel disease Cyclooxygenase-2 and 5-lipoxygenase in dogs with chronic enteropathies.Lamina Propria CD4+LAP+ Regulatory T Cells Are Increased in Active Ulcerative Colitis but Show Increased IL-17 Expression and Reduced Suppressor Activity.Inflammatory bowel disease—from mechanisms to treatment strategies.Mucosal biomarkers in inflammatory bowel disease: key pathogenic players or disease predictors?The mode of actions of the Adacolumn therapeutic leucocytapheresis in patients with inflammatory bowel disease: a concise review.Changes of the cytokine profile in inflammatory bowel diseases.Why interleukin-10 supplementation does not work in Crohn's disease patients.Metabolic inflammation in inflammatory bowel disease: crosstalk between adipose tissue and bowel.Intestinal inflammation without weight loss decreases bone density and growth.IL-10 enhances CCL2 release and chemotaxis induced by CCL16 in human monocytes.The Impact of Western Diet and Nutrients on the Microbiota and Immune Response at Mucosal Interfaces.Frequency of CD4+CD161+ T Cell and Interleukin-10 Expression in Inflammatory Bowel Diseases.Basal lymphoid aggregates in ulcerative colitis colon: a site for regulatory T cell action.Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via toll-like receptor 2 signaling.Role of cytokines in inflammatory bowel disease.Macrophage phenotype in the subclinical gut inflammation of patients with ankylosing spondylitis.The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease.Utility of the housekeeping genes 18S rRNA, beta-actin and glyceraldehyde-3-phosphate-dehydrogenase for normalization in real-time quantitative reverse transcriptase-polymerase chain reaction analysis of gene expression in human T lymphocytes.Cytolytic capabilities of lamina propria and intraepithelial lymphocytes in normal and chronically inflamed human intestine.Anti-inflammatory role of interleukin-15 in Crohn's disease.Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naïve ulcerative colitis during active and quiescent disease.Involvement of CYP1B1 in interferon γ-induced alterations of epithelial barrier integrity.Immunological pathogenesis of inflammatory bowel disease.The expression profile of functional regulatory T cells, CD4+CD25high+/forkhead box protein P3+, in patients with ulcerative colitis during active and quiescent disease.

P2860

Q24610882-CDD0174C-22EC-4C2E-A4B7-3B58CA0F268F Q26827500-63B977EC-D0DD-445E-8196-3D2729951667 Q29040489-8AFA5260-E0F6-4B77-AE99-AAB96C67120A Q34019489-6C4BBF70-5766-420E-970E-DB926B2CF214 Q34106001-880B015E-AD70-4928-B8C1-93855D96FE72 Q34409155-5EAE19AA-CADA-49EC-8CE6-653DAE7CB4A1 Q34632853-07BC5708-23AB-47A7-9DA0-A02A3AF87245 Q35011055-B392EEEE-0926-41AD-A668-A4DA8BFF3802 Q35109247-0E33E69A-3FED-49CD-85AA-9CBE6331E435 Q35231496-11444482-8B3E-4A5F-B6BD-625DF9780E37 Q35589806-126F2FA6-B357-4BD8-AC0C-50979605B9E6 Q35939519-A39047AA-3EFF-404C-BC8F-7AC805BAF9A5 Q36229402-165C0BF2-97F5-4A34-BBA6-8A187C93C11F Q36700662-213B5A53-64D2-4198-A55F-D441B1013677 Q36803301-40AAF6B8-B915-49D5-8887-8836A85E4E66 Q36969231-81320BA4-7E21-4E90-B958-8E7D3F8B0878 Q36975533-992797ED-D8A7-4139-B311-E43AA7553AAE Q37118477-52D7E655-FBB4-4A94-AF5E-0B3D62C0BE3A Q37730101-3A0E9081-55F3-494F-A4C9-E9E3FF6E12A4 Q37762230-C7A4F82F-1E1E-4252-BD14-2EEECCA9ADAA Q37809574-A7B54837-F0A8-4C78-90E9-B3AC37C14F1D Q38058782-80938191-64C8-4545-8F36-58B02B53127A Q38120519-667C595F-1E5E-4755-B7C6-0941ADB0AA29 Q38253468-82C7C0BA-C4CF-43EB-90EA-1BEB2A17BC60 Q38812259-E2258CCE-765D-4C9E-8149-843E348DE90C Q40423865-893F8DFF-A344-4519-B0A7-E13E8B7AF043 Q41159836-36C52CDD-A86A-41E2-B896-7D8EF28A7AA2 Q42002157-2604C062-6027-448C-BC49-4A7B2472DAA2 Q42523517-F11CC631-FC12-48DD-86BE-CAE146425E93 Q42704864-0C768D86-35F2-454E-A4B5-1A97896B11EB Q43065113-019E696F-12D6-4BB4-9901-75969E8B4E86 Q44258886-1398DC94-C6B8-4348-B582-556C567094C8 Q44539365-FDBE4C83-0403-41D1-8B47-61E943EE584B Q44925185-1F988A0D-1BF1-472F-8AC1-C39558DDA27C Q44967043-B643F8FE-1E97-4B1D-941F-55C3654BB262 Q45285888-F99E8EA5-7EF6-432C-9789-3F4E56CDB4E3 Q46303987-82D3AC49-2EB8-442E-A49E-4DF04D30D334 Q47323640-D3ED0600-FFE8-4DD0-80E8-89971DFF96EB Q50042967-5947A567-6F7B-4CDD-9B2D-DA4434F120E1 Q51765029-4D0B0C83-2355-48D4-930F-5BE4A9867381

P2860

Over-expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis.

http://www.wikidata.org/entity/Q42447593

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Over-expression of interleukin ...... ith active ulcerative colitis.

@en

Over-expression of interleukin ...... ith active ulcerative colitis.

@nl

type

label

Over-expression of interleukin ...... ith active ulcerative colitis.

@en

Over-expression of interleukin ...... ith active ulcerative colitis.

@nl

prefLabel

Over-expression of interleukin ...... ith active ulcerative colitis.

@en

Over-expression of interleukin ...... ith active ulcerative colitis.

@nl

P1433

Q42447593-4B4BDF2A-A73B-4BDC-8E3E-745CEBCC6F18

P1476

Q42447593-43511FAD-04CB-4286-82F8-76A9F329521E

P2093

Q42447593-37DE86F8-FB51-4A47-81E3-B048485C2A72

Q42447593-40F32404-4FAD-40AA-A8C2-A4A1EEA5DE56

Q42447593-66C6CA4A-2EEE-4997-91E2-BC7E8B6D2672

Q42447593-776CE83A-8D32-4D04-888A-81A4FF97A88F

Q42447593-81FFF97C-3A09-463E-834E-38C4CAAB87B3

Q42447593-82197307-761E-472D-AA9A-F7241D3E1C73

Q42447593-991009EA-07B2-497E-944C-DD983E6696B8

Q42447593-E2CB4998-5987-4899-AE8E-3CD7CB3CDE22

P2860

Q42447593-00550DFA-47ED-43A3-B3D5-166C41ADD23E

Q42447593-06027E1D-6AD3-4E64-80EA-78068E13E673

Q42447593-088C50DA-E52F-4101-8FDC-360C1A040B3E

Q42447593-22AF9996-3E67-4355-B816-6AF97FB58629

Q42447593-24F22715-8CE6-45BF-B50E-75E99E67D6FD

Q42447593-310B248F-50B5-4749-A443-10E19A82F4DA

Q42447593-37475AB0-1E42-4447-9A5B-6A3156BE021A

Q42447593-404BF34B-A721-4264-8FF8-DFE1A1D7DE1F

Q42447593-5460C519-6F89-4A0A-AC5C-8EE56946198B

Q42447593-6DC7FE2D-29CC-436A-AF5E-D45B5C35B843

P304

Q42447593-8F3067DE-8EFB-41D8-AC23-240E30CF986D

P31

Q42447593-0742A0B0-B4A3-4243-9F18-59A3C52F080F

P356

Q42447593-43EAF263-1774-4C2C-8A52-73BA4C51D02D

P433

Q42447593-7BB61A0D-9FCD-4B27-8715-091B059DBECE

P478

Q42447593-3D9B5D3F-3F42-49AC-84D6-447A5F68C556

P50

Q42447593-0FFEA472-3AB7-44A8-9E04-24A7FC2C670E

P577

Q42447593-4DB1065B-EA5E-47C4-98B7-76E34997ED68

P5875

Q42447593-7C86CB2E-1E8F-4CFC-8C97-164DF5FF364A

P698

Q42447593-77DF1B26-7BDF-4233-925F-8542FFF82902

P921

Q42447593-443254e0-c8f3-41fa-a61c-06d694ca8697

P932

Q42447593-3512C15D-5B29-4FEE-A12F-AE1069363B35

P356

J.1365-2249.2003.02268.X

P1433

Clinical and Experimental Immunology

P1476

Over-expression of interleukin ...... ith active ulcerative colitis.

@en

P2093

A Bas

http://www.w3.org/2001/XMLSchema#string

A Danielsson

http://www.w3.org/2001/XMLSchema#string

A Oberg

http://www.w3.org/2001/XMLSchema#string

G Forsberg

http://www.w3.org/2001/XMLSchema#string

M M-W Yeung

http://www.w3.org/2001/XMLSchema#string

M-L Hammarstrom

http://www.w3.org/2001/XMLSchema#string

S Hammarstrom

http://www.w3.org/2001/XMLSchema#string

S Melgar

http://www.w3.org/2001/XMLSchema#string

P2860

Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice

Treatment of Crohn's disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon gamma

Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

IL-10 inhibits cytokine production by activated macrophages

Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group.

Interleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirus-specific CD8(+) cytotoxic T lymphocytes.

Recent developments in the immunology of inflammatory bowel disease.

Insights from mouse models of colitis.

An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation

P304

127-137

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1365-2249.2003.02268.X

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

134

http://www.w3.org/2001/XMLSchema#string

P50

P577

2003-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10566572

http://www.w3.org/2001/XMLSchema#string

P698

12974765

http://www.w3.org/2001/XMLSchema#string

P921

P932

1808826

http://www.w3.org/2001/XMLSchema#string